Freiburg, Germany

Dieter Marme


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1989-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dieter Marme

Introduction

Dieter Marme is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating Alzheimer's disease. With a total of 2 patents, Marme's work reflects a commitment to advancing medical science.

Latest Patents

Marme's latest patents include "Stable hyperforin salts, method for producing same and their use in the treatment of Alzheimer's disease" and "2-acyloxypropylamino derivatives, processes for the preparation thereof." The first patent focuses on stable hyperforin salts that can be utilized in therapeutic applications for Alzheimer's. The second patent covers a novel series of 2-acyloxypropylamine derivatives, detailing processes for their preparation, compositions containing them, and methods for their use. These compounds are particularly noted for their activity in inhibiting protein kinase C and thrombocyte aggregation stimulated by diacylglycerols.

Career Highlights

Throughout his career, Dieter Marme has worked with reputable companies such as Willmar Schwabe GmbH & Co. and Goedecke Aktiengesellschaft. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the pharmaceutical industry.

Collaborations

Marme has collaborated with notable professionals in his field, including Shyam Sunder Chatterjee and Clemens Erdelmeier. These partnerships have further enhanced his research and development efforts.

Conclusion

Dieter Marme's contributions to the field of pharmaceuticals, particularly through his innovative patents, demonstrate his dedication to improving treatments for Alzheimer's disease. His work continues to inspire advancements in medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…